The Centers for Disease Control and Prevention’s advisory panel made it clear on Thursday that they prefer Pfizer and Moderna vaccines over Johnson & Johnson.
The advisory linked blood clot issues that appear to be associated with the J&J vaccine.
Here & Now‘s Celeste Headlee speaks with STAT reporter Matthew Herper about what it means for people who have the J&J vaccine.
This article was originally published on WBUR.org.
Copyright 2022 NPR. To see more, visit https://www.npr.org.